Respiri Limited ( (AU:RSH) ) has shared an announcement.
Respiri Limited announced the results of its general meeting held on April 16, 2025, where all resolutions were passed. The resolutions included changes to the company name and approvals related to share issues, reflecting strategic decisions that could impact the company’s future operations and shareholder value.
More about Respiri Limited
Respiri Limited is an e-Health SaaS company that focuses on respiratory health management and Remote Patient Monitoring services. Their innovative technology, wheezo®, is a smart device that detects wheeze, a common symptom of asthma and other respiratory diseases, providing an objective measure of airway limitation. The company aims to improve asthma management and reduce hospital admissions, with operations based in Melbourne, Australia, and New York, USA.
YTD Price Performance: 4.00%
Technical Sentiment Signal: Hold
Current Market Cap: $36.91M
See more insights into RSH stock on TipRanks’ Stock Analysis page.